These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35236385)

  • 1. Convergence of patient- and physician-reported outcomes in the French National Registry of Facioscapulohumeral Dystrophy.
    Sanson B; Stalens C; Guien C; Villa L; Eng C; Rabarimeriarijaona S; Bernard R; Cintas P; Solé G; Tiffreau V; Echaniz-Laguna A; Magot A; Juntas Morales R; Boyer FC; Nadaj-Pakleza A; Jacquin-Piques A; Béroud C; Sacconi S;
    Orphanet J Rare Dis; 2022 Mar; 17(1):96. PubMed ID: 35236385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The French National Registry of patients with Facioscapulohumeral muscular dystrophy.
    Guien C; Blandin G; Lahaut P; Sanson B; Nehal K; Rabarimeriarijaona S; Bernard R; Lévy N; Sacconi S; Béroud C
    Orphanet J Rare Dis; 2018 Dec; 13(1):218. PubMed ID: 30514324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of the patient-reported "Facial Function Scale" for facioscapulohumeral muscular dystrophy.
    Mul K; Wijayanto F; Loonen TGJ; Groot P; Vincenten SCC; Knuijt S; Groothuis JT; Maal TJJ; Heskes T; Voermans NC; Engelen BGMV
    Disabil Rehabil; 2023 May; 45(9):1530-1535. PubMed ID: 35575310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, set-up and utility of the UK facioscapulohumeral muscular dystrophy patient registry.
    Evangelista T; Wood L; Fernandez-Torron R; Williams M; Smith D; Lunt P; Hudson J; Norwood F; Orrell R; Willis T; Hilton-Jones D; Rafferty K; Guglieri M; Lochmüller H
    J Neurol; 2016 Jul; 263(7):1401-8. PubMed ID: 27159994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Facioscapulohumeral Muscular Dystrophy-Health Index: Development and evaluation of a disease-specific outcome measure.
    Varma A; Weinstein J; Seabury J; Rosero S; Engebrecht C; Wagner E; Zizzi C; Luebbe EA; Dilek N; McDermott MP; Kissel J; Sansone V; Heatwole C
    Muscle Nerve; 2023 Oct; 68(4):422-431. PubMed ID: 37610084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Dutch registry for facioscapulohumeral muscular dystrophy: Cohort profile and longitudinal patient reported outcomes.
    Kools J; Deenen JC; Blokhuis AM; Verbeek AL; Voermans NC; van Engelen BG
    Neuromuscul Disord; 2023 Dec; 33(12):964-971. PubMed ID: 38016873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. If you build a rare disease registry, will they enroll and will they use it? Methods and data from the National Registry of Myotonic Dystrophy (DM) and Facioscapulohumeral Muscular Dystrophy (FSHD).
    Hilbert JE; Kissel JT; Luebbe EA; Martens WB; McDermott MP; Sanders DB; Tawil R; Thornton CA; Moxley RT;
    Contemp Clin Trials; 2012 Mar; 33(2):302-11. PubMed ID: 22155025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Facing facial weakness: psychosocial outcomes of facial weakness and reduced facial function in facioscapulohumeral muscular dystrophy.
    van de Geest-Buit WA; Rasing NB; Mul K; Deenen JCW; Vincenten SCC; Siemann I; Lanser A; Groothuis JT; van Engelen BG; Custers JAE; Voermans NC
    Disabil Rehabil; 2023 Jul; 45(15):2507-2516. PubMed ID: 35815498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Italian National Registry for FSHD: an enhanced data integration and an analytics framework towards Smart Health Care and Precision Medicine for a rare disease.
    Bettio C; Salsi V; Orsini M; Calanchi E; Magnotta L; Gagliardelli L; Kinoshita J; Bergamaschi S; Tupler R
    Orphanet J Rare Dis; 2021 Nov; 16(1):470. PubMed ID: 34736505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The facioscapulohumeral muscular dystrophy Rasch-built overall disability scale (FSHD-RODS).
    Mul K; Hamadeh T; Horlings CGC; Tawil R; Statland JM; Sacconi S; Corbett AJ; Voermans NC; Faber CG; van Engelen BGM; Merkies ISJ
    Eur J Neurol; 2021 Jul; 28(7):2339-2348. PubMed ID: 33838063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Facioscapulohumeral Muscular Dystrophy European Patient Survey: Assessing Patient Reported Disease Burden and Preferences in Clinical Trial Participation.
    McNiff MM; Hawkins S; Haase B; Bullivant J; McIver T; Mitelman O; Emery N; Tasca G; Voermans N; Diaz-Manera J
    J Neuromuscul Dis; 2024; 11(2):459-472. PubMed ID: 38277300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of functional impairment in Facioscapulohumeral muscular dystrophy.
    Statland JM; Tawil R
    Muscle Nerve; 2014 Apr; 49(4):520-7. PubMed ID: 23873337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medication adherence in patients with myotonic dystrophy and facioscapulohumeral muscular dystrophy.
    Fitzgerald BP; Conn KM; Smith J; Walker A; Parkhill AL; Hilbert JE; Luebbe EA; Moxley RT
    J Neurol; 2016 Dec; 263(12):2528-2537. PubMed ID: 27734165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facioscapulohumeral Muscular Dystrophies.
    Wagner KR
    Continuum (Minneap Minn); 2019 Dec; 25(6):1662-1681. PubMed ID: 31794465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facioscapulohumeral dystrophy in children: design of a prospective, observational study on natural history, predictors and clinical impact (iFocus FSHD).
    Goselink RJ; Schreuder TH; Mul K; Voermans NC; Pelsma M; de Groot IJ; van Alfen N; Franck B; Theelen T; Lemmers RJ; Mah JK; van der Maarel SM; van Engelen BG; Erasmus CE
    BMC Neurol; 2016 Aug; 16():138. PubMed ID: 27530735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel clinical tool to classify facioscapulohumeral muscular dystrophy phenotypes.
    Ricci G; Ruggiero L; Vercelli L; Sera F; Nikolic A; Govi M; Mele F; Daolio J; Angelini C; Antonini G; Berardinelli A; Bucci E; Cao M; D'Amico MC; D'Angelo G; Di Muzio A; Filosto M; Maggi L; Moggio M; Mongini T; Morandi L; Pegoraro E; Rodolico C; Santoro L; Siciliano G; Tomelleri G; Villa L; Tupler R
    J Neurol; 2016 Jun; 263(6):1204-14. PubMed ID: 27126453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facioscapulohumeral muscular dystrophy Health Index: Japanese translation and validation study.
    Fujino H; Takahashi MP; Nakamura H; Heatwole CR; Takada H; Kuru S; Ogata K; Enomoto K; Hayashi Y; Imura O; Matsumura T
    Disabil Rehabil; 2024 Mar; ():1-10. PubMed ID: 38555736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large genotype-phenotype study in carriers of D4Z4 borderline alleles provides guidance for facioscapulohumeral muscular dystrophy diagnosis.
    Ricci G; Mele F; Govi M; Ruggiero L; Sera F; Vercelli L; Bettio C; Santoro L; Mongini T; Villa L; Moggio M; Filosto M; Scarlato M; Previtali SC; Tripodi SM; Pegoraro E; Telese R; Di Muzio A; Rodolico C; Bucci E; Antonini G; D'Angelo MG; Berardinelli A; Maggi L; Piras R; Maioli MA; Siciliano G; Tomelleri G; Angelini C; Tupler R
    Sci Rep; 2020 Dec; 10(1):21648. PubMed ID: 33303865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Serum Interleukin 6 Levels as a Disease Severity Biomarker in Facioscapulohumeral Muscular Dystrophy.
    Gros M; Nunes AM; Daoudlarian D; Pini J; Martinuzzi E; Barbosa S; Ramirez M; Puma A; Villa L; Cavalli M; Grecu N; Garcia J; Siciliano G; Solé G; Juntas-Morales R; Jones PL; Jones T; Glaichenhaus N; Sacconi S
    J Neuromuscul Dis; 2022; 9(1):83-93. PubMed ID: 34459413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrating clinical and genetic observations in facioscapulohumeral muscular dystrophy.
    Mul K; van den Boogaard ML; van der Maarel SM; van Engelen BG
    Curr Opin Neurol; 2016 Oct; 29(5):606-13. PubMed ID: 27389814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.